Aurora Cannabis Inc. (ACB) |
| 3.89 0.06 (1.57%) 02-26 16:00 |
| Open: | 3.82 |
| High: | 3.9 |
| Low: | 3.78 |
| Volume: | 496,164 |
| Market Cap: | 221(M) |
| PE Ratio: | -3.57 |
| Exchange: | NASDAQ Global Select |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 5.24 |
| Resistance 1: | 4.49 |
| Pivot price: | 3.61 |
| Support 1: | 3.74 |
| Support 2: | 3.28 |
| 52w High: | 6.665 |
| 52w Low: | 3.28 |
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
| EPS | -1.090 |
| Book Value | 6.910 |
| PEG Ratio | 0.00 |
| Gross Profit | 2.370 |
| Profit Margin (%) | -22.51 |
| Operating Margin (%) | 2.32 |
| Return on Assets (ttm) | -4.4 |
| Return on Equity (ttm) | -15.5 |
Thu, 26 Feb 2026
(ACB) Market Insights and Trading Signals (ACB:CA) - Stock Traders Daily
Fri, 20 Feb 2026
Aurora Cannabis Inc. (ACB) Stock Analysis: Exploring A Potential 79.68% Upside - DirectorsTalk Interviews
Tue, 17 Feb 2026
Aurora to Participate in the TD Cowen 46th Annual Health Care Conference - PR Newswire
Sun, 15 Feb 2026
Canaccord is Bullish on Aurora Cannabis Inc. (ACB) - Yahoo Finance
Wed, 11 Feb 2026
Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand - PR Newswire
Wed, 04 Feb 2026
Aurora Cannabis (NASDAQ: ACB) launches U.S.$100M at-the-market share program - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |